oxazoles has been researched along with 3,4-dihydroxyphenylglycol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berlin, I; Hergueta, T; Payan, C; Puech, AJ; Robin, L; Thiede, HM; Zimmer, R | 1 |
| Aubin, N; Curet, O; Damoiseau, G; Jarreau, FX; Rovei, V; Sontag, N | 1 |
| Allain, H; Cimarosti, I; Curet, O; Dubruc, C; Durrieu, G; Gandon, JM; Jezequel, S; le Coz, F; Patat, A; Rosenzweig, P; Zieleniuk, I | 1 |
| Curet, O; Dubruc, C; Durrieu, G; Legangneux, E; Patat, A; Rosenzweig, P; Zieleniuk, I | 1 |
| Birk, KL; Cohen, AF; De Puy, ME; De Smet, M; Fisher, AL; Goldberg, MR; Musson, DG; Sterrett, A; Van Gerven, JM; Van Haarst, AD | 1 |
| Guth, PS; Hendricson, AW | 1 |
4 trial(s) available for oxazoles and 3,4-dihydroxyphenylglycol
| Article | Year |
|---|---|
Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects.
Topics: Adult; Benzamides; Double-Blind Method; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Psychometrics; Psychophysiology | 1990 |
Pharmacodynamics and pharmacokinetics of two dose regimens of befloxatone, a new reversible and selective monoamine oxidase inhibitor, at steady state in healthy volunteers.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Humans; Male; Metabolic Clearance Rate; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Oxazoles | 1996 |
Clinical pharmacology of befloxatone: a brief review.
Topics: Adult; Aged; Brain; Cognition; Dose-Response Relationship, Drug; Drug Interactions; Electroencephalography; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase Inhibitors; Oxazoles; Placebos; Psychomotor Performance; Tyramine | 1998 |
The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers.
Topics: Adult; Area Under Curve; Benzamides; Biotransformation; Blood Pressure; Cross-Over Studies; Double-Blind Method; Female; Half-Life; Humans; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 1999 |
2 other study(ies) available for oxazoles and 3,4-dihydroxyphenylglycol
| Article | Year |
|---|---|
Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. I. Biochemical profile.
Topics: Animals; Biogenic Monoamines; Brain; Duodenum; Humans; Liver; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Oxazoles; Rats; Rats, Sprague-Dawley | 1996 |
Transmitter release from Rana pipiens vestibular hair cells via mGluRs: a role for intracellular Ca(++) release.
Topics: Animals; Auditory Pathways; Calcium Signaling; Electrophysiology; Hair Cells, Auditory; In Vitro Techniques; Macrocyclic Compounds; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Oxazoles; Rana pipiens; Receptors, Metabotropic Glutamate; Ryanodine; Semicircular Canals; Thapsigargin | 2002 |